Joseph E Palys

Array ( [id] => 3873254 [patent_doc_number] => 05747243 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Retrovirus detection method' [patent_app_type] => 1 [patent_app_number] => 8/621016 [patent_app_country] => US [patent_app_date] => 1996-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 7266 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747243.pdf [firstpage_image] =>[orig_patent_app_number] => 621016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3840180 [patent_doc_number] => 05707814 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-13 [patent_title] => 'CD8.sup.+ cell antiviral factor' [patent_app_type] => 1 [patent_app_number] => 8/610942 [patent_app_country] => US [patent_app_date] => 1996-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6983 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/707/05707814.pdf [firstpage_image] =>[orig_patent_app_number] => 610942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3821004 [patent_doc_number] => 05759551 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines' [patent_app_type] => 1 [patent_app_number] => 8/446692 [patent_app_country] => US [patent_app_date] => 1995-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 39758 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/759/05759551.pdf [firstpage_image] =>[orig_patent_app_number] => 446692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3969220 [patent_doc_number] => 05886163 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'HIV-1 antigens, antibody compositions related thereto, and therapeutic and prophylactic uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/530146 [patent_app_country] => US [patent_app_date] => 1995-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 42 [patent_no_of_words] => 16240 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/886/05886163.pdf [firstpage_image] =>[orig_patent_app_number] => 530146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4060024 [patent_doc_number] => 05864027 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-26 [patent_title] => 'HIV envelope polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/448603 [patent_app_country] => US [patent_app_date] => 1995-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 24316 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/864/05864027.pdf [firstpage_image] =>[orig_patent_app_number] => 448603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3656772 [patent_doc_number] => 05627035 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-06 [patent_title] => 'Peptides that block human immunodeficiency virus and methods of use thereof' [patent_app_type] => 1 [patent_app_number] => 8/494763 [patent_app_country] => US [patent_app_date] => 1995-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13001 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/627/05627035.pdf [firstpage_image] =>[orig_patent_app_number] => 494763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3753827 [patent_doc_number] => 05843446 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines' [patent_app_type] => 1 [patent_app_number] => 8/488351 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 39 [patent_no_of_words] => 35868 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843446.pdf [firstpage_image] =>[orig_patent_app_number] => 488351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3873986 [patent_doc_number] => 05763572 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'HTLV-II peptide antigens' [patent_app_type] => 1 [patent_app_number] => 8/485068 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 12270 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763572.pdf [firstpage_image] =>[orig_patent_app_number] => 485068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3721582 [patent_doc_number] => 05700469 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-23 [patent_title] => 'HIV-1 core protein fragments' [patent_app_type] => 1 [patent_app_number] => 8/474008 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2848 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 336 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/700/05700469.pdf [firstpage_image] =>[orig_patent_app_number] => 474008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4055420 [patent_doc_number] => 05863718 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-26 [patent_title] => 'Small peptides which inhibit to T-4 receptors and act as immunogens' [patent_app_type] => 1 [patent_app_number] => 8/486678 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 4684 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/863/05863718.pdf [firstpage_image] =>[orig_patent_app_number] => 486678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3993597 [patent_doc_number] => 05858374 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Purified AIDS-associated virus' [patent_app_type] => 1 [patent_app_number] => 8/484944 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 4313 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858374.pdf [firstpage_image] =>[orig_patent_app_number] => 484944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3936532 [patent_doc_number] => 05871933 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'HTLV-I and HTLV-II peptide antigens and methods' [patent_app_type] => 1 [patent_app_number] => 8/483353 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 12301 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/871/05871933.pdf [firstpage_image] =>[orig_patent_app_number] => 483353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3777276 [patent_doc_number] => 05817763 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Macrophage-derived inflammatory mediator (MIP-1.alpha. and MIP-1.beta.)' [patent_app_type] => 1 [patent_app_number] => 8/480347 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 15722 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817763.pdf [firstpage_image] =>[orig_patent_app_number] => 480347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3774464 [patent_doc_number] => 05756674 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates' [patent_app_type] => 1 [patent_app_number] => 8/473576 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 12484 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756674.pdf [firstpage_image] =>[orig_patent_app_number] => 473576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3857262 [patent_doc_number] => 05795577 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-18 [patent_title] => 'Viral vector coding for a glycoprotein of the virus responsible for A.I.D.S.' [patent_app_type] => 1 [patent_app_number] => 8/481622 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8433 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/795/05795577.pdf [firstpage_image] =>[orig_patent_app_number] => 481622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3830705 [patent_doc_number] => 05814441 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'HTLV-I and HTLV-II peptide antigens and methods' [patent_app_type] => 1 [patent_app_number] => 8/481598 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 12314 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814441.pdf [firstpage_image] =>[orig_patent_app_number] => 481598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3643616 [patent_doc_number] => 05683702 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-04 [patent_title] => 'Primary and secondary immunization with different physio-chemical forms of antigen' [patent_app_type] => 1 [patent_app_number] => 8/470767 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1432 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/683/05683702.pdf [firstpage_image] =>[orig_patent_app_number] => 470767 [rel_patent_id] =>[rel_patent_doc_number] =>)